Skip to main content
. 2014 Dec 18;5(4):34–46. doi: 10.5365/WPSAR.2014.5.4.007

Figure 7.

Expenditure on MDR-TB and RR-TB by funding source, year and selected country*, WHO Western Pacific Region, 2007–2013

MDR-TB, multidrug-resistant tuberculosis; RR-TB, rifampicin-resistance tuberculosis.

* Countries that reported at least 10 MDR-TB cases in 2013.

Figure 7